Iris Spiliopoulou
- Infectious Diseases top 1%
- Molecular Biology top 10%
- Clinical Biochemistry top 0.5%
- Epidemiology top 5%
- Molecular Medicine top 1%
- Co-authors
- Efthimia PetinakiAntigoni FokaEvangelos D. AnastassiouMarkos MarangosMatthaios Papadimitriou‐OlivgerisG. DimitracopoulosFevronia KolonitsiouChristina Bartzavali
- Topics
- Antimicrobial Resistance in Staphylococcus (69 papers)Bacterial biofilms and quorum sensing (48 papers)Bacterial Identification and Susceptibility Testing (44 papers)
- Partner nations
- GreeceSwitzerlandFrance
In The Last Decade
Iris Spiliopoulou
135 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 121
- Infectious Diseases 1.3k
- Molecular Biology 930
- Clinical Biochemistry 696
- Epidemiology 662
- Molecular Medicine 490
Countries citing papers authored by Iris Spiliopoulou
This map shows the geographic impact of Iris Spiliopoulou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Spiliopoulou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Spiliopoulou more than expected).
Fields of papers citing papers by Iris Spiliopoulou
This network shows the impact of papers produced by Iris Spiliopoulou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Spiliopoulou. The network helps show where Iris Spiliopoulou may publish in the future.
Co-authorship network of co-authors of Iris Spiliopoulou
This figure shows the co-authorship network connecting the top 25 collaborators of Iris Spiliopoulou. A scholar is included among the top collaborators of Iris Spiliopoulou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Spiliopoulou. Iris Spiliopoulou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 9 | |
| 4 | 16 | |
| 5 | 12 | |
| 6 | 31 | |
| 7 | 2 | |
| 8 | 14 | |
| 9 | 44 | |
| 10 | 8 | |
| 11 | 7 | |
| 12 | 46 | |
| 13 | EPIDEMIOLOGY OF CHRONIC HEPATITIS C VIRUS INFECTION IN HIGH RISK GROUPS | 5 |
| 14 | Clonal Evolution and Antibiotic Resistance Profile of Methicillin-Resistant Staphylococcus aureus in Greece during a Five-Year Period | 1 |
| 15 | 10 | |
| 16 | 41 | |
| 17 | 4 | |
| 18 | 12 | |
| 19 | 13 | |
| 20 | Beta-thalassaemia and the prevalence of HCV viraemia. | 2 |
About Iris Spiliopoulou
Iris Spiliopoulou is a scholar working on Clinical Biochemistry, Infectious Diseases and Molecular Medicine, having authored 136 papers that have together received 2.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (69 papers), Bacterial biofilms and quorum sensing (48 papers) and Bacterial Identification and Susceptibility Testing (44 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (207 citations), Clinical Biochemistry (696 citations) and Molecular Medicine (490 citations). Iris Spiliopoulou has collaborated with scholars based in Greece, Switzerland and France. Frequent co-authors include Efthimia Petinaki, Antigoni Foka, Evangelos D. Anastassiou, Markos Marangos, Matthaios Papadimitriou‐Olivgeris, G. Dimitracopoulos, Fevronia Kolonitsiou, Christina Bartzavali, Chrisoula D. Scopa and Constantine Vagianos. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Spine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.